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Abstract 
Herein, fabrication of polyurethane glucose sensor membranes doped with next generation 
biocompatible macromolecular nitric oxide-releasing scaffolds (hyperbranched polyesters, 
hyperbranched polyurethanes, alginate) was reported. Nitric oxide-releasing S-nitrosothiol-
modified hyperbranched polyesters-doped membranes achieved extended nitric oxide-release (> 
48 h) and promising in vitro sensor performance (sensitivity 20.9 nA/mM, linear dynamic range 
0 – 15 mM). Nitric oxide-releasing N-diazeniumdiolate-modified hyperbranched polyurethanes-
doped membranes showed desirable smooth membrane morphology, but had relatively limited 
nitric oxide-releasing duration (up to 18 h) and half-life (~ 0.4 h). Nitric oxide-releasing N-
diazeniumdiolate-modified alginate-doped membranes showed significantly longer nitric oxide-
releasing half-life (~ 1.2 h) with hyperbranched polyurethanes, but their nitric oxide-releasing 
duration (< 20 h) was still limited. Challenges for future studies on this subject lie in extending 
the nitric oxide-releasing lifetimes of the membranes and obtaining more control over the nitric 
oxide-release kinetics. 
 
Introduction 
Diabetes is a worldwide problem. In 2012, there were 1.5 million diabetes-associated deaths 
globally, making the disease the eighth leading cause of death.1 Since diabetes is characterized 
by an inability to regulate blood glucose levels, monitoring blood glucose levels is essential in 
the management of diabetes.1-3 Implantable glucose sensors capable of continuous accurate 
glucose monitoring provide an ideal approach to this problem.2, 3 Unfortunately, such sensors 
often induce a robust foreign body response resulting in local inflammation and eventual 
isolation (via granulation tissue) of the sensor from native tissue, significantly reducing the 
analytical performance of the sensor.4 The sensors often require frequent recalibration or 
replacement, limiting their clinical utility.4 Nitric oxide (NO), a diatomic free radical naturally 
produced in human body, is known to enhance wound healing and mitigate the foreign body 
response.4-6 Recent research has focused on developing NO-releasing glucose sensor membranes 
to improve in vivo glucose sensor performance.2-11 (Figure 1) The Schoenfisch lab has worked 
to dope polyurethane (PU) sensor membranes with macromolecular NO-releasing scaffolds.5-11 
The sensor membranes were shown to possess a diverse range of NO payloads and NO-release 
kinetics. In vivo testing revealed that PU membranes doped with NO-releasing silica 
nanoparticles (SNPs) enhanced overall sensor performance by decreasing the foreign body 
response in a 10-day study.6 However, the SNPs leached from the PU membranes, and such 
particles could remain in the human body for extended periods (as long as 30 days) with 
potential toxicity concerns.8,12,13 To maximize the potential of NO-releasing materials for clinical 
applications, a scaffold that minimizes the negative effects of leaching is desired. A new type of 
glucose sensor membranes utilizes novel biocompatible macromolecular NO-releasing scaffolds 
with potential biodegradability and tunable NO-release properties in hope of obtaining glucose 
sensor membranes with high biocompatibility and sustained NO-release. 
 
 Figure 1. Implantable glucose sensors with and without NO-releasing scaffolds 
 
Herein, we report on the fabrication of PU glucose sensor membranes doped with novel NO-
releasing systems, including hyperbranched polyesters (HBPE), hyperbranched polyurethanes 
(HBPU), and alginate. (Figure 1) The NO-release characteristics, morphology of the 
membranes, and in vitro performance of glucose sensors with these membranes were assessed to 
determine their potential for use in implantable glucose sensor membranes. 
 
 Figure 2. Novel macromolecular NO-releasing scaffolds 
 
Experimental 
Fabrication of NO-releasing HBPE-doped PU membranes Third generation HBPE were 
synthesized and modified with S-nitrosothiol functional groups based on literature reported 
protocols to form NO-releasing HBPE (Scheme 1).14, 15 To fabricate NO-releasing HBPE-doped 
PU membranes, NO-releasing HBPE (24 mg/mL) and PU (60 mg/mL) were dissolved in 
tetrahydrofuran (THF). The mixture was coated onto mock glucose sensors (stainless steel wires, 
357 μm dia.) by the loop casting method as reported in literature.4-8 Briefly, 6.5 μL of the 
mixture was coated evenly onto the sensor (or mock sensor) surface by a stainless steel wire ring 
(1 mm dia.). The casting process was repeated to achieve multiple coats onto the sensor surface. 
The sensors were left to dry briefly under ambient conditions between each coating process. 
 
 
Scheme 1. Synthesis of NO-releasing HBPE 
 
Fabrication of NO-releasing HBPU-doped PU membranes HBPU were synthesized 
based on literature reported protocols.16 Then, HBPU (1.0 g) was dissolved in 10 mL N, N-
dimethylformamide (DMF) with triphenylphosphine (1.538 g). Br2 (0.30 mL) was added slowly 
and the mixture was allowed to react at 75 ℃ for 24 h. Brown product (HBPU-Br) was collected 
by precipitation in diethyl ether. The collected HBPU-Br was dissolved in 5 mL DMF with 3.0 
mL propylamine for 72 h to form HBPU-NH. HBPU-NH was precipitated and washed in diethyl 
ether. HBPU-NH (10 mg/mL) was then dissolved in anhydrous methanol with sodium methoxide 
(94.5 mM), and the mixture was allowed to react with gaseous NO (150 psi) for 72 h. The 
resulting N-diazeniumdiolate-modified HBPU was collected by precipitation in anhydrous 
diethyl ether. (Scheme 2) NO-releasing HBPU with a range of concentrations (25, 50, 100 
mg/mL) in PU (50 mg/mL) were dissolved in 3:1 DMF: THF (v/v). The solution was coated onto 
mock sensors by the loop casting method to form 10 coatings. To increase membrane 
hydrophobicity, an additional topcoat was applied to some mock sensors by loop casting a 
hydrophobic PU (TPU, water uptake 0.20 ± 0.18 mg water/mg PU, 50 mg/mL solution in 50 
v/v% DMF, 50 v/v% THF) onto the coated mock sensors. 
 
 
Scheme 2. Synthesis of NO-releasing HBPU 
 
Fabrication of NO-releasing alginate-doped PU membranes Commercially available 
alginate (300 kDa) was degraded to 5 kDa to achieve better mixability with polyurethane. 
Briefly, 2.0 g alginate (300 kDa) was allowed to react with 40 mL hydrogen peroxide (4.9 M) at 
85 ℃ for 1 h. Alginate (5 kDa) was collected by precipitation in ethanol. Alginate (5 kDa) was 
then modified by dipropylenetriamine (DPTA) through reactions with N-(3-
dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide 
(NHS). DPTA modified alginate (15 mg/mL) was dissolved in aqueous solution of NaOH (50 
mM) and reacted with gaseous NO (150 psi) for 72 h. The NO-releasing alginate formed was 
collected by precipitation in anhydrous ethanol. (Scheme 3) Solid NO-releasing alginate was 
ground up and mixed with 50 mg/mL polyurethane (PU) solution in 3:1 DMF: THF to form a 
suspension, which was coated onto mock glucose sensors by the loop casting method to form 10 
coats.  
 
 Scheme 3. Synthesis of NO-releasing alginate 
 
Characterization of NO-release from the PU membranes The NO payload and NO-
release kinetics from the PU membranes were measured under physiological conditions using 
Griess assay and a chemiluminescence NO analyzer (NOA). For Griess assay, mock sensors 
were immersed in phosphate buffered saline (PBS, pH 7.4) and incubated at 37 ℃. The NO 
released from the mock sensors was quantified by treating the solution with the Griess reagents.7 
For NOA, the mock sensors were incubated in pH 7.4 PBS at 37 ℃. NO released from the mock 
sensors was carried into the NO analyzer by a constant nitrogen flow. This NO undergoes a 
chemiluminescence reaction with ozone, releasing a photon that can be measured by an optical 
detector.5-11 For the NO-releasing HBPE-doped membranes, 500 mM 
diethylenetriaminepentaacetic acid (DTPA) was added to the PBS to prevent Cu(II)-induced NO 
release.15 NO payload of the membrane ([NO]t) was measured as the total amount of NO 
released; NO-releasing duration (td) was measured as the time for the NO flux to drop below 1 
pmol cm-2 s-1; NO-releasing half-life (t1/2) was measured as the time for the release of one half of 
[NO]t. 
 
In vitro sensor performance Amperometric needle-type glucose sensors were constructed 
from a Ir-Pt wire working electrode and a Ag|AgCl reference electrode. Sensors coated with 
polyurethane membranes were soaked in PBS at 37 ℃, and glucose was added gradually to the 
solution to obtain a calibration curve. Linear dynamic range (LDR) of the sensor was defined as 
the range of glucose concentration in which the calibration curve is linear (R2 > 0.98). Sensitivity 
of the sensor is defined as the slope of the calibration curve in the determined LDR. 
 
Characterization of membrane morphology To evaluate the morphology of the PU 
membranes, mock glucose sensors coated with the membranes were characterized by scanning 
electron microscopy (SEM). 
 
Results and Discussion 
NO-releasing HBPE-doped PU membranes 
HBPE are a type of hyperbranched organic polymers that have been found to be both 
biocompatible and biodegradable.14,15,17 NO-releasing HBPE was developed by Yang et al. for 
therapeutic applications.15 The high NO-payload (up to 2 μmol/mg) and relatively long NO-
release half-lives (up to 3 h) made NO-releasing HBPE favorable for glucose sensor 
applications.15 Additionally, NO-releasing HBPE utilizes S-nitrosothiol as the NO-donor group, 
which is the NO-donor group utilized naturally by organisms.15, 18 Therefore, NO-releasing 
HBPE was chosen as the first NO-releasing scaffold to be investigated in this study. 
 
 
Figure 3. NO-release from NO-releasing HBPE-doped PU membranes, characterized by Griess 
assay 
 
Table 1. NO payloads of NO-releasing HBPE-doped PU membranes, measured by Griess assay 
PU a Number of coatings [NO]t (μmol/cm2) 
SP-60D-60 
5 0.82 ± 0.15 
10 1.71 ± 0.28 
HPU 
5 0.76 ± 0.28 
10 1.59 ± 0.21 
a. PU water uptake (mg water/ mg PU): 1.73 ± 0.26 (SP-60D-60), 0.63 ± 0.34 (HPU). 
 
NO-release from NO-releasing HBPE-doped PU membranes was characterized by Griess 
assay (Figure 3) because it was expected to have relatively low and constant NO-flux.8,15 The 
results showed that the membranes were capable of releasing NO for > 48 h. Such a relatively 
long NO-release duration can be promising for clinical applications. The NO payloads of the 
membranes were found to be tunable by varying the number of coatings. (Table 1) The NO 
payloads (Table 1) and NO-release kinetics (Figure 3) of the NO-releasing HBPE-doped 
membranes were not significantly influenced by the hydrophobicity of the membranes. Such an 
observation was expected, because the NO-release from the S-nitrosothiol functional groups is a 
free radical process, which should not be affected by the hydrophobicity of the membranes.15,18 
 
 
Figure 4. Amperometric sensor response of needle-type glucose sensors with A) 5 coatings, B) 
10 coatings of NO-releasing HBPE-doped SP-60D-60 membranes, and the corresponding 
calibration curves within LDRs. Each increment of current corresponds to one increment of 
glucose concentration. 
 
To assess the potentials of the sensor membranes in clinical sensor applications, in vitro 
glucose calibrations were performed using needle-type glucose sensors. (Figure 4) While both 
the sensor with 5 coatings (sensitivity 21.8 nA/mM, LDR 0 – 12 mM) and the sensor with 10 
coatings (sensitivity 20.9 nA/mM, LDR 0 – 15 mM) showed similar sensitivity and LDRs, the 
sensor with 5 coatings had a much smaller S/N ratio. This was likely due to the fact that 5 
coatings of PU membranes were not enough to prevent the sensor from Reacting to fluctuations 
in local glucose concentrations. Therefore, it was concluded that 10 coatings of PU membranes 
were more preferable for sensor applications. The sensitivity of the sensors was comparable to 
that of the sensors coated with NO-releasing materials-doped PU membranes developed in 
previous studies.8 The LDR of the sensor with 10 coatings (0 – 15 mM) was able to cover the 
physiological blood glucose range (1 – 15 mM)19, proving that glucose sensors coated with NO-
releasing HBPE-doped PU membranes meet the minimum requirements for clinical application 
and can be pursued further for this application.  
 
NO-releasing HBPU-doped PU membranes 
Though NO-releasing HBPE-doped PU membranes can achieve necessary properties for 
clinical applications, the free radical nature of NO-releasing HBPE posed the challenge of 
controlling the NO-release kinetics of the membranes. Therefore, NO-releasing HBPU, a new 
type of macromolecular NO-releasing scaffold utilizing N-diazeniumdiolate NO-donor groups 
(Scheme 2) was investigated for sensor membrane applications. NO-release from N-
diazeniumdiolates is triggered by protons.18 So the kinetics of N-diazeniumdiolate-based NO-
releasing scaffolds can theoretically be tuned by varying PU membrane hydrophobicity. HBPU 
is a type of highly biocompatible hyperbranched polymer.16 It is also relatively hydrophobic, 
making it unlikely to leach from the PU membranes.16 As such, NO-releasing HBPU was chosen 
to be the first N-diazeniumdiolate based NO-releasing scaffold investigated in this study. 
 
Table 2. NO-releasing characteristics of NO-releasing HBPU-doped PU membranes, measured 
by NOA 
PU (10 coatings) a 
[HBPU]  
(mg/mg PU) 
[NO]t  
(μmol cm-2) 
td (h) t1/2 (h) 
HP-93A-100 0.5 0.52 ± 0.34 16.0 ± 5.1 0.35 ± 0.18 
HPU/topcoat b 0.5 0.85 ± 0.30 17.5 ± 5.2 0.40 ± 0.29 
HP-93A-100/topcoat b 
0.5 0.69 ± 0.27 13.9 ± 2.6 0.41 ± 0.21 
1 1.23 ± 0.11 15.6 ± 2.3 0.42 ± 0.17 
a. PU water uptake (mg water/ mg PU): 2.56 ± 0.31 (HP-93A-100), 0.63 ± 0.34 (HPU); b. With one TPU topcoat 
containing no HBPU 
 
Because N-diazeniumdiolates tend to show high and variable NO-flux at the early stage of 
their NO-release,8,18 the NO-release from NO-releasing HBPU-doped PU membranes was 
measured by NOA, which allows real-time monitoring of NO-release. (Table 2) The NO-release 
characteristics ([NO]t, td, t1/2) of NO-releasing HBPU-doped PU membranes were evaluated as a 
function of the concentrations of NO-releasing HBPU in the membranes, as well as membrane 
hydrophobicity. It was found that the [NO]t is tunable by varying the concentration of NO-
releasing HBPU in the membrane. Thus, the number of coats on the sensors can be held constant 
at the number that yields the most preferable sensor performance (10 coatings). The td of the NO-
releasing HBPU-doped membranes was relatively short (< 20 h), which may limit their clinical 
applications. Of note, the expected control over the NO-release kinetics of the membranes by 
varying membrane hydrophobicity was not achieved. After varying the hydrophobicity of PU, 
changing the concentration of NO-releasing HBPU in the membranes, or applying hydrophobic 
TPU topcoats, the t1/2 of the membranes remained relatively constant (~ 0.40 h). A possible 
explanation of such discrepancy between expectation and observation is that 10 coatings of PU 
might not be sufficient to show a significant impact on the rate of proton diffusion to the 
scaffold. Future study need to be conducted to test the validity of this hypothesis. 
 
 
Figure 5. Morphology of A) HP-93A-100, B) HP-93A-100 with one TPU topcoat, C) HPU, D) 
HPU with one TPU topcoat, doped with NO-releasing HBPU (0.5 mg HBPU/mg PU), 10 
coatings on mock glucose sensors 
 
 Figure 6. Morphology of HP-93A-100 membranes doped with A) 0.5 mg HBPU/mg PU, B) 1 
mg HBPU/mg PU, C) 2 mg HBPU/mg PU, 10 coatings on mock glucose sensors 
 
Previous studies have shown that smooth sensor membranes tend to reduce foreign body 
response in human body.6,8 Therefore, morphology of NO-releasing HBPU-doped PU 
membranes was evaluated as a function of PU type (Figure 5) and HBPU concentration (Figure 
6). Smooth membranes preferable for clinical applications were achieved with HP-93A-100 at 
low HBPU concentration (Figure 5A). The morphology of the HPU membrane was slightly less 
smooth than that of the HP-93A-100 membrane, but the difference was not significant (Figure 
5C). Introducing TPU topcoats interrupted the smoothness of the membranes (Figure 5B&D), 
which was likely due to the fact that the viscosity of TPU solutions prevented it from being 
uniformly coated onto the mock sensors by the loop casting method. Such a problem should be 
resolvable by optimizing the solvent composition for TPU during the loop casting process, and is 
unlikely to negatively impact the potentials of the membranes for clinical applications. 
 When increasing the concentration of NO-releasing HBPU in the membranes, the 
membrane morphology deteriorated significantly. (Figure 6) It is likely that the high 
concentration of HBPU in the PU matrix disrupts the polymeric structure of the membrane. Such 
an observation suggests that, for potential applications of these membranes, the concentration of 
NO-releasing scaffolds in the membranes need to be limited at ≤ 1 mg scaffold/mg PU. 
 
NO-releasing alginate-doped PU membranes 
Although NO-releasing HBPU-doped PU membranes were capable of achieving desirable 
membrane morphology, their future applications were limited by the relatively short NO-release 
durations of these membranes. Therefore, NO-releasing alginate, a novel macromolecular NO-
releasing scaffold utilizing N-diazeniumdiolate NO-donor groups, was investigated. Alginate is a 
naturally produced linear polysaccharide extracted from brown algae (Phaeophyceae).21-23 
Alginate has been found to be highly biocompatible and biodegradable, and has been utilized in a 
range of biomedical applications, including drug delivery, wound dressing, therapeutic cell 
entrapment.21-23 The Schoenfisch group has been working on developing NO-releasing alginate 
for the treatment of cystic fibrosis, and it was found that NO-releasing alginate can achieve 
relatively long NO-releasing durations and half-lives. It was hypothesized that NO-releasing 
alginate-doped PU membranes could achieve extended and tunable NO-releasing lifetimes for 
application in glucose sensor membranes. 
 
Table 3. NO-releasing characteristics of NO-releasing alginate-doped PU membranes, measured 
by NOA 
PU (10 coats) a [NO]t (μmol cm-2) td (h) t1/2 (h) 
HP-93A-100 1.30 ± 0.08 18.8 ± 1.0 1.23 ± 0.14 
HPU 1.13 ± 0.32 19.9 ± 1.3 1.15 ± 0.18 
a. PU water uptake (mg water/ mg PU): 2.56 ± 0.31 (HP-93A-100), 0.63 ± 0.34 (HPU) 
 
The NO-release kinetics from NO-releasing alginate-doped PU membranes were 
characterized by NOA. (Table 3) The NO-releasing half-lives of NO-releasing alginate-doped 
membranes (~ 1.2 h) were significantly longer than those of NO-releasing HBPU-doped 
membranes (~ 0.4 h, Table 2). However, the NO-releasing durations of these membranes were 
still relative short (< 20 h). Of note, the control over NO-release kinetics by changing membrane 
morphology was not achieved, which was likely due to the same reason as the similar trends 
observed in NO-releasing HBPU-doped membranes. 
 
Conclusions 
This study demonstrated the possibility of fabricating PU glucose sensor membranes doped 
with novel biocompatible macromolecular NO-release scaffolds. These membranes were found 
to be able to achieve tunable NO payloads and smooth membrane morphology. Sensors with 
such membranes showed good sensor performance in vitro. However, the relatively short NO-
releasing lifetimes will likely limit the clinical applications. Future studies on fabrication of 
biocompatible macromolecular NO-releasing scaffolds therefore need to be focused on extending 
the NO-releasing lifetimes of the membranes and achieving more control over the NO-release 
kinetics from these membranes. 
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